Contact
searchSearch
HMP Global
Login

Advertisement

Advertisement

ADVERTISEMENT

Psych Congress Network

Advertisement

Advertisement

Featured

Secondary Analysis Shows Which Patients With TRD Benefit Most From Ketamine
News
Secondary Analysis Shows Which Patients With TRD Benefit Most From Ketamine
07/24/2024
Ketamine was associated with greater treatment response than electroconvulsive therapy in patients with nonpsychotic treatment-resistant depression who had moderately severe or severe pretreatment symptoms and who initiated treatment as...
Ketamine was associated with greater treatment response than electroconvulsive therapy in patients with nonpsychotic treatment-resistant depression who had moderately severe or severe pretreatment symptoms and who initiated treatment as...
Ketamine was associated with...
07/24/2024
Psych Congress Network
FDA Considers Supplemental NDA for Brexpiprazole Plus Sertraline for PTSD
News
FDA Considers Supplemental NDA for Brexpiprazole Plus Sertraline for PTSD
07/24/2024
The US Food and Drug Administration recently accepted a supplemental New Drug Application for brexpiprazole in combination with sertraline for the treatment of adults with PTSD, announced codevelopers Otsuka Pharmaceutical Co. Ltd. and H....
The US Food and Drug Administration recently accepted a supplemental New Drug Application for brexpiprazole in combination with sertraline for the treatment of adults with PTSD, announced codevelopers Otsuka Pharmaceutical Co. Ltd. and H....
The US Food and Drug...
07/24/2024
Psych Congress Network
FDA building sign
News
FDA Declines to Approve OX124 Nasal Spray for Opioid Overdose Treatment
07/23/2024
The US Food and Drug Administration (FDA) has again declined Swedish drug manufacturer Orexo’s New Drug Application (NDA) for OX125, a high-dose naloxone nasal spray for opioid overdose reversal.
The US Food and Drug Administration (FDA) has again declined Swedish drug manufacturer Orexo’s New Drug Application (NDA) for OX125, a high-dose naloxone nasal spray for opioid overdose reversal.
The US Food and Drug...
07/23/2024
Psych Congress Network
Three illustrated faces, one sad, one neutral, one happy, with a human hand picking up the happy face
Expert Insights Quiz
HIPPA Considerations for Social Media
07/22/2024
Hone your telehealth practice and knowledge with this quiz!
Hone your telehealth practice and knowledge with this quiz!
Hone your telehealth practice...
07/22/2024
Psych Congress Network
One in 7 Patients Experience Antidepressant Discontinuation Symptoms, Study Says
News
One in 7 Patients Experience Antidepressant Discontinuation Symptoms, Study Says
07/22/2024
Including non-specific effects, approximately 15% or 1 in 6 to 7 patients experience antidepressant discontinuation symptoms, according to recent systematic review and meta-analysis results published in The Lancet Psychiatry. 
Including non-specific effects, approximately 15% or 1 in 6 to 7 patients experience antidepressant discontinuation symptoms, according to recent systematic review and meta-analysis results published in The Lancet Psychiatry. 
Including non-specific effects,...
07/22/2024
Psych Congress Network
Drs Podesta and Carbray
Podcasts
Managing Comorbid Bipolar Disorder & SUD: Treatment and Communication
07/22/2024
Drs Podesta and Carbray examine available treatments, recommended strategies, and how clinicians can better communicate with patients with this comorbidity.
Drs Podesta and Carbray examine available treatments, recommended strategies, and how clinicians can better communicate with patients with this comorbidity.
Drs Podesta and Carbray examine...
07/22/2024
Psych Congress Network
News
Some Antipsychotics Linked To Elevated Pneumonia Risk
07/17/2024
Pneumonia in patients with schizophrenia is associated with the use of specific antipsychotics, according to study findings published in JAMA Psychiatry.
Pneumonia in patients with schizophrenia is associated with the use of specific antipsychotics, according to study findings published in JAMA Psychiatry.
Pneumonia in patients with...
07/17/2024
Psych Congress Network
How many symptoms must be present in order to diagnose adult ADHD?
Quiz
How many symptoms must be present in order to diagnose adult ADHD?
07/17/2024
Challenge your diagnostic knowledge!
Challenge your diagnostic knowledge!
Challenge your diagnostic...
07/17/2024
Psych Congress Network
Combining TMS or tDCS With Certain Medications May Reduce MDD Symptoms
News
Combining TMS or tDCS With Certain Medications May Reduce MDD Symptoms
07/16/2024
Combining certain medications or psychotherapy with TMS or tDCS may decrease symptoms of MDD, though some limitations still exist, according to a review published in the Harvard Review of Psychiatry. 
Combining certain medications or psychotherapy with TMS or tDCS may decrease symptoms of MDD, though some limitations still exist, according to a review published in the Harvard Review of Psychiatry. 
Combining certain medications or...
07/16/2024
Psych Congress Network
Nishi Bhopal, MD
Q&As
The Importance of Sleep Education for Mental Health Clinicians
07/16/2024
Nishi Bhopal, MD, discusses how mental health clinicians can more closely incorporate sleep disorder screening, diagnosis, and treatment into their practices.
Nishi Bhopal, MD, discusses how mental health clinicians can more closely incorporate sleep disorder screening, diagnosis, and treatment into their practices.
Nishi Bhopal, MD, discusses how...
07/16/2024
Psych Congress Network
Grief-Related Psychiatric Conditions Common Among Bereaved Adults
News
Grief-Related Psychiatric Conditions Common Among Bereaved Adults
07/16/2024
PTSD, MDD, and PGD appear highly prevalent and comorbid among bereaved US adults, particularly those who experienced a traumatic loss of a psychologically close other.
PTSD, MDD, and PGD appear highly prevalent and comorbid among bereaved US adults, particularly those who experienced a traumatic loss of a psychologically close other.
PTSD, MDD, and PGD appear highly...
07/16/2024
Psych Congress Network

Advertisement

Advertisement

Advertisement

From the Newsrooms

Nishi Bhopal, MD
Q&As
The Importance of Sleep Education for Mental Health Clinicians
07/16/2024
Nishi Bhopal, MD, discusses how mental health clinicians can more closely incorporate sleep disorder screening, diagnosis, and treatment into their practices.
Nishi Bhopal, MD, discusses how mental health clinicians can more closely incorporate sleep disorder screening, diagnosis, and treatment into their practices.
Nishi Bhopal, MD, discusses how...
07/16/2024
Psych Congress Network
Chepke
Videos
Differential Diagnosis of Tardive Dyskinesia and Other Movement Disorders
07/09/2024
Craig Chepke, MD, DFAPA, shares the importance of differentiating tardive dyskinesia (TD) from other movement disorders .
Craig Chepke, MD, DFAPA, shares the importance of differentiating tardive dyskinesia (TD) from other movement disorders .
Craig Chepke, MD, DFAPA, shares...
07/09/2024
Psych Congress Network
Nishi Bhopal, MD
Q&As
Social Media Etiquette for Mental Health Clinicians
07/01/2024
Nishi Bhopal, MD, explains how to maintain professionalism while using social media to promote one'e telehealth practice.
Nishi Bhopal, MD, explains how to maintain professionalism while using social media to promote one'e telehealth practice.
Nishi Bhopal, MD, explains how...
07/01/2024
Psych Congress Network
Nishi Bhopal, MD
Q&As
Leveraging Social Media to Support Your Practice
06/20/2024
Nishi Bhopal, MD, telehealth practitioner, providers insight into how mental health clinicians can utilize social media to improve patient outcomes and combat misinformation.
Nishi Bhopal, MD, telehealth practitioner, providers insight into how mental health clinicians can utilize social media to improve patient outcomes and combat misinformation.
Nishi Bhopal, MD, telehealth...
06/20/2024
Psych Congress Network
Dr Jain
Videos
Navigating Cardiometabolic Symptoms With Conventional Bipolar Disorder Therapies
06/18/2024

With Rakesh Jain, MD

With Rakesh Jain, MD
In this video, Dr Jain discusses possible cardiometabolic symptoms that can occur in bipolar disorder treatment and how clinicians can avoid them from the start.
In this video, Dr Jain discusses possible cardiometabolic symptoms that can occur in bipolar disorder treatment and how clinicians can avoid them from the start.
In this video, Dr Jain discusses...
06/18/2024
Psych Congress Network
Kevin Williams, MS, MPAS, PA-C
Videos
Helping Patients Navigate Psychopharmacological and Social Challenges in Tardive Dyskinesia
06/05/2024

Featuring Kevin Williams, MS, MPAS, PA-C

Featuring Kevin Williams, MS, MPAS, P...
evin Williams, MS, MPAS, PA-C, Psych Congress Steering Committee Member, at the 2024 NP Institute, Nurse Williams details how clinicians can more closely incorporate caregivers into patient treatment plans.
evin Williams, MS, MPAS, PA-C, Psych Congress Steering Committee Member, at the 2024 NP Institute, Nurse Williams details how clinicians can more closely incorporate caregivers into patient treatment plans.
evin Williams, MS, MPAS, PA-C,...
06/05/2024
Psych Congress Network
Nurse Kempf
Videos
Optimizing Nursing Home and Geriatric Patient Mental Health Care With Brooke Kempf, PMHNP-BC
06/03/2024

With Brooke Kempf, PMHNP-BC

With Brooke Kempf, PMHNP-BC
Join Nurse Kempf for this essential discussion on geriatric mental health care, and learn practical tips and strategies for providing compassionate and effective treatment to this vulnerable population.
Join Nurse Kempf for this essential discussion on geriatric mental health care, and learn practical tips and strategies for providing compassionate and effective treatment to this vulnerable population.
Join Nurse Kempf for this...
06/03/2024
Psych Congress Network
Sandhya Prashad, MD
Q&As
Unlocking the Power of Ketamine With Sandhya Prashad, MD
05/30/2024

Featuring Sandhya Prashad, MD

Featuring Sandhya Prashad, MD
Sandhya Prashad, MD, discusses ketamine applications for treatment-resistant depression.
Sandhya Prashad, MD, discusses ketamine applications for treatment-resistant depression.
Sandhya Prashad, MD, discusses...
05/30/2024
Psych Congress Network
Patients With Anhedonia More Severely Affected Than Other Patients With MDD
News
Patients With Anhedonia More Severely Affected Than Other Patients With MDD
05/30/2024
Evi Arthur
Patients with major depressive disorder and anhedonia may have more severe depressive symptoms than patients with MDD and no/low anhedonia (other-MDD), according to results presented via poster at Psych Congress Elevate. 
Patients with major depressive disorder and anhedonia may have more severe depressive symptoms than patients with MDD and no/low anhedonia (other-MDD), according to results presented via poster at Psych Congress Elevate. 
Patients with major depressive...
05/30/2024
Psych Congress Network
Dr Craig Chepke
Exclusive Interview
Dr Craig Chepke Appointed Scientific Director of Psych Congress, to Co-Chair Upcoming Elevate Meeting
05/21/2024
Meagan Thistle
Dr Craig Chepke discusses his aspirations in his new role, shares insights from his career journey, and reflects on the impact of Psych Congress events on his clinical practice.
Dr Craig Chepke discusses his aspirations in his new role, shares insights from his career journey, and reflects on the impact of Psych Congress events on his clinical practice.
Dr Craig Chepke discusses his...
05/21/2024
Psych Congress Network

Quizzes

Three illustrated faces, one sad, one neutral, one happy, with a human hand picking up the happy face
Expert Insights Quiz
HIPPA Considerations for Social Media
07/22/2024
Hone your telehealth practice and knowledge with this quiz!
Hone your telehealth practice and knowledge with this quiz!
Hone your telehealth practice...
07/22/2024
Psych Congress Network
How many symptoms must be present in order to diagnose adult ADHD?
Quiz
How many symptoms must be present in order to diagnose adult ADHD?
07/17/2024
Challenge your diagnostic knowledge!
Challenge your diagnostic knowledge!
Challenge your diagnostic...
07/17/2024
Psych Congress Network
How easy is it to switch patients from olanzapine to olanzapine samidorphan?
Quiz
How easy is it to switch patients from olanzapine to olanzapine samidorphan?
07/16/2024
Do you remember this insight from Dr Jain?
Do you remember this insight from Dr Jain?
Do you remember this insight...
07/16/2024
Psych Congress Network
quiz
Quiz
Percentage of Patients With Major or Mild Frontotemporal NCD Found With Alzheimer Disease Pathology at Autopsy
07/11/2024
What percentage of patients presenting with a syndrome suggestive of major or mild frontotemporal neurocognitive disorder (NCD) are found at autopsy to have Alzheimer disease pathology, according to the DSM-5-TR?
What percentage of patients presenting with a syndrome suggestive of major or mild frontotemporal neurocognitive disorder (NCD) are found at autopsy to have Alzheimer disease pathology, according to the DSM-5-TR?
What percentage of patients...
07/11/2024
Psych Congress Network
A cartoon illustration of a brain with two medical professionals standing on either side; one holds up a magnifying glass to the brain
Quiz
Differences in ADHD Symptoms Due to Sex
07/02/2024
Do you know what the DSM-5-TR says on this topic? Find out with this quiz!
Do you know what the DSM-5-TR says on this topic? Find out with this quiz!
Do you know what the DSM-5-TR...
07/02/2024
Psych Congress Network
quiz
Quiz
Which factor is NOT consideration when choosing an antidepressant medication?
06/28/2024
Which factor is NOT a consideration when choosing an antidepressant medication according to the APA's major depressive disorder practice guidelines? Take the quiz to find out!
Which factor is NOT a consideration when choosing an antidepressant medication according to the APA's major depressive disorder practice guidelines? Take the quiz to find out!
Which factor is NOT a...
06/28/2024
Psych Congress Network
quiz
Quiz
Which symptoms of schizophrenia must be present to make a diagnosis?
06/21/2024
Two of the 5 characteristic symptoms of schizophrenia must be present for a diagnosis to be made. At least one of these must be which of the following, according to the DSM-5-TR? Take the quiz!
Two of the 5 characteristic symptoms of schizophrenia must be present for a diagnosis to be made. At least one of these must be which of the following, according to the DSM-5-TR? Take the quiz!
Two of the 5 characteristic...
06/21/2024
Psych Congress Network
an illustrated head in profile with brain, against a pink background.
Quiz
DSM-5-TR: Opioid-Induced Mental Disorders
06/18/2024
Put your OUD knowledge to the test with this quiz!
Put your OUD knowledge to the test with this quiz!
Put your OUD knowledge to the...
06/18/2024
Psych Congress Network
Can stimulant use increase risk of heart damage in young adults with ADHD?
Quiz
Can stimulant use increase risk of heart damage in young adults with ADHD?
06/17/2024
Time for a pop quiz!
Time for a pop quiz!
Time for a pop quiz!
06/17/2024
Psych Congress Network
Risk of developing CUD is highest before what age?
Quiz
Risk of developing CUD is highest before what age?
06/14/2024
Do you remember this study?
Do you remember this study?
Do you remember this study?
06/14/2024
Psych Congress Network

Recent FDA Updates

The US Food and Drug Administration headquarters sign.
FDA Approves Donanemab for Early Alzheimer Disease Treatment
07/02/2024
The US Food and Drug Administration has issued a highly-anticipated decision: the approval of donanemab—to be marketed as Kisunla by manufacturer Eli Lilly—for the treatment of early Alzheimer disease.
The US Food and Drug Administration has issued a highly-anticipated decision: the approval of donanemab—to be marketed as Kisunla by manufacturer Eli Lilly—for the treatment of early Alzheimer disease.
The US Food and Drug...
07/02/2024
Psych Congress Network
Video Game Treatment for Adults With ADHD Cleared by FDA
News
Video Game Treatment for Adults With ADHD Cleared by FDA
07/02/2024
AKL-T01 is indicated for adults with primarily inattentive or combined-type ADHD who have a demonstrated attention issue.
AKL-T01 is indicated for adults with primarily inattentive or combined-type ADHD who have a demonstrated attention issue.
AKL-T01 is indicated for adults...
07/02/2024
Psych Congress Network
FDA Approves First Liquid, Non-Stimulant for Pediatric ADHD
News
FDA Approves First Liquid, Non-Stimulant for Pediatric ADHD
06/11/2024
Evi Arthur
The FDA approved Tris Pharma, Inc.’s ONYDA™ XR (clonidine hydrochloride), a once-daily extended-release oral suspension medication, for the treatment of ADHD in patients 6 years and older.
The FDA approved Tris Pharma, Inc.’s ONYDA™ XR (clonidine hydrochloride), a once-daily extended-release oral suspension medication, for the treatment of ADHD in patients 6 years and older.
The FDA approved Tris Pharma,...
06/11/2024
Psych Congress Network

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

NEW NP Institute Online Learning Hub

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Brooke Kempf
Clinical Pearls
When to Consider Adjunctive Treatments for Depression
04/03/2024
Brooke Kempf, MSN, PMHNP-BC, offers her thoughts on how to approach the nuanced decision-making process of augmenting antidepressants.
Brooke Kempf, MSN, PMHNP-BC, offers her thoughts on how to approach the nuanced decision-making process of augmenting antidepressants.
Brooke Kempf, MSN, PMHNP-BC,...
04/03/2024
Psych Congress NP Institute

Expert Insights

Drs Podesta and Carbray
Podcasts
Managing Comorbid Bipolar Disorder & SUD: Treatment and Communication
07/22/2024
Drs Podesta and Carbray examine available treatments, recommended strategies, and how clinicians can better communicate with patients with this comorbidity.
Drs Podesta and Carbray examine available treatments, recommended strategies, and how clinicians can better communicate with patients with this comorbidity.
Drs Podesta and Carbray examine...
07/22/2024
Psych Congress Network
Nishi Bhopal, MD
Q&As
The Importance of Sleep Education for Mental Health Clinicians
07/16/2024
Nishi Bhopal, MD, discusses how mental health clinicians can more closely incorporate sleep disorder screening, diagnosis, and treatment into their practices.
Nishi Bhopal, MD, discusses how mental health clinicians can more closely incorporate sleep disorder screening, diagnosis, and treatment into their practices.
Nishi Bhopal, MD, discusses how...
07/16/2024
Psych Congress Network
Amber Hoberg, MSN, APRN, PMHNP-BC
Videos
Comparing VMAT-2 Inhibitor Options for Tardive Dyskinesia Treatment
07/15/2024
Amber Hoberg, MSN, APRN, PMHNP-BC, discusses the key clinical differences between the 2 FDA-approved treatment options for tardive dyskinesia.
Amber Hoberg, MSN, APRN, PMHNP-BC, discusses the key clinical differences between the 2 FDA-approved treatment options for tardive dyskinesia.
Amber Hoberg, MSN, APRN,...
07/15/2024
Psych Congress Network
Amber Hoberg, MSN, APRN, PMHNP-BC
Videos
Comparing VMAT-2 Inhibitor Options for Tardive Dyskinesia Treatment
07/15/2024
Amber Hoberg, MSN, APRN, PMHNP-BC, discusses the key clinical differences between the 2 FDA-approved treatment options for tardive dyskinesia.
Amber Hoberg, MSN, APRN, PMHNP-BC, discusses the key clinical differences between the 2 FDA-approved treatment options for tardive dyskinesia.
Amber Hoberg, MSN, APRN,...
07/15/2024
Psych Congress Network
hoberg
Videos
Tardive Dyskinesia Refresher: Causes, Identification, and Impact
07/10/2024
Refresh your clinical toolbox with information on TD's impact on patients and the essential requirements for successful treatment.
Refresh your clinical toolbox with information on TD's impact on patients and the essential requirements for successful treatment.
Refresh your clinical toolbox...
07/10/2024
Psych Congress Network

Live Meetings

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Pearls
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

Advertisement

Advertisement

Sign Up

Psych Congress Network Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement